BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37926068)

  • 21. [Expression patterns and prognostic values of Nrf2 and Keap1 in nasopharyngeal carcinoma].
    Ma XK; Liu JS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):678-682. PubMed ID: 29771085
    [No Abstract]   [Full Text] [Related]  

  • 22. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer.
    Ahtikoski AM; Kangas J; Salonen R; Puistola U; Karihtala P
    Anticancer Res; 2019 Feb; 39(2):585-590. PubMed ID: 30711933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear factor erythroid 2-like 2 (Nrf2) expression in end-stage liver disease.
    Kurzawski M; Dziedziejko V; Urasińska E; Post M; Wójcicki M; Miętkiewski J; Droździk M
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):87-95. PubMed ID: 22459801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
    Isohookana J; Haapasaari KM; Soini Y; Karihtala P
    Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of hormone-dependent breast cancer seems to be influenced by KEAP1, NRF2 and GSTM1 genetic polymorphisms.
    Almeida M; Soares M; Ramalhinho AC; Moutinho JF; Breitenfeld L
    Mol Biol Rep; 2019 Jun; 46(3):3213-3224. PubMed ID: 30941643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular mechanism of Nrf2-Keap1 signaling pathway in the antioxidant defense response induced by BaP in the scallop Chlamys farreri.
    Wang H; Pan L; Xu R; Si L; Zhang X
    Fish Shellfish Immunol; 2019 Sep; 92():489-499. PubMed ID: 31220575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism.
    Song MY; Lee DY; Chun KS; Kim EH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
    Wong TF; Yoshinaga K; Monma Y; Ito K; Niikura H; Nagase S; Yamamoto M; Yaegashi N
    Int J Gynecol Cancer; 2011 Nov; 21(8):1428-35. PubMed ID: 21897267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zearalenone induced oxidative stress in the jejunum in postweaning gilts through modulation of the Keap1-Nrf2 signaling pathway and relevant genes1.
    Cheng Q; Jiang S; Huang L; Ge J; Wang Y; Yang W
    J Anim Sci; 2019 Apr; 97(4):1722-1733. PubMed ID: 30753491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
    Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
    J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.
    Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Shirmohamadi M; Khaze V; Samadi N
    Biomed Pharmacother; 2018 Aug; 104():458-464. PubMed ID: 29793178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells.
    Jung KA; Kwak MK
    Oxid Med Cell Longev; 2013; 2013():423965. PubMed ID: 23766854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
    Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
    Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.
    Suzuki T; Yamamoto M
    J Biol Chem; 2017 Oct; 292(41):16817-16824. PubMed ID: 28842501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.
    Zhang P; Singh A; Yegnasubramanian S; Esopi D; Kombairaju P; Bodas M; Wu H; Bova SG; Biswal S
    Mol Cancer Ther; 2010 Feb; 9(2):336-46. PubMed ID: 20124447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer.
    Delgobo M; Gonçalves RM; Delazeri MA; Falchetti M; Zandoná A; Nascimento das Neves R; Almeida K; Fagundes AC; Gelain DP; Fracasso JI; Macêdo GB; Priori L; Bassani N; Bishop AJR; Forcelini CM; Moreira JCF; Zanotto-Filho A
    Free Radic Biol Med; 2021 Dec; 177():58-71. PubMed ID: 34673143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
    Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.